Cargando…

CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer

BACKGROUND: The study of immune surveillance in the tumour microenvironment is leading to the development of new biomarkers and therapies. The present research focuses on the expression of CD5 and CD6—two lymphocyte surface markers involved in the fine tuning of TCR signaling—as potential prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreno-Manuel, Andrea, Jantus-Lewintre, Eloisa, Simões, Ines, Aranda, Fernando, Calabuig-Fariñas, Silvia, Carreras, Esther, Zúñiga, Sheila, Saenger, Yvonne, Rosell, Rafael, Camps, Carlos, Lozano, Francisco, Sirera, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481598/ https://www.ncbi.nlm.nih.gov/pubmed/32953486 http://dx.doi.org/10.21037/tlcr-19-445

Ejemplares similares

MicroRNAs: Promising New Antiangiogenic Targets in Cancer
por: Gallach, Sandra, et al.
Publicado: (2014)

MicroRNA profiling associated with non-small cell lung cancer: next generation sequencing detection, experimental validation, and prognostic value
por: Gallach, Sandra, et al.
Publicado: (2017)

Characterization of Circulating T Cell Receptor Repertoire Provides Information about Clinical Outcome after PD-1 Blockade in Advanced Non-Small Cell Lung Cancer Patients
por: Dong, Ning, et al.
Publicado: (2021)

Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer
por: Zhang, Feiyu, et al.
Publicado: (2021)

Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers
por: Usó, Marta, et al.
Publicado: (2016)

Biological insights in non-small cell lung cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Immunomodulatory effects of soluble CD5 on experimental tumor models
por: Simões, Inês T., et al.
Publicado: (2017)

Lung tumorspheres reveal cancer stem cell-like properties and a score with prognostic impact in resected non-small-cell lung cancer
por: Herreros-Pomares, Alejandro, et al.
Publicado: (2019)

Potential Non-Invasive Biomarkers for Early Diagnosis of Oral Squamous Cell Carcinoma
por: Dikova, Valentina, et al.
Publicado: (2021)

Identification of TRPC6 as a possible candidate target gene within an amplicon at 11q21-q22.2 for migratory capacity in head and neck squamous cell carcinomas
por: Bernaldo de Quirós, Sandra, et al.
Publicado: (2013)

Serum metabolomic profiling facilitates the non-invasive identification of metabolic biomarkers associated with the onset and progression of non-small cell lung cancer
por: Puchades-Carrasco, Leonor, et al.
Publicado: (2016)

Analysis of Exosomal Cargo Provides Accurate Clinical, Histologic and Mutational Information in Non-Small Cell Lung Cancer
por: Duréndez-Sáez, Elena, et al.
Publicado: (2022)

Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies
por: Palanca-Ballester, Cora, et al.
Publicado: (2021)

CD6 modulates thymocyte selection and peripheral T cell homeostasis
por: Orta-Mascaró, Marc, et al.
Publicado: (2016)

NGS‐based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment
por: Sánchez‐Herrero, Estela, et al.
Publicado: (2021)

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer
por: García-Foncillas, Jesús, et al.
Publicado: (2018)

CD4(+)CD25(+ )immunoregulatory T cells may not be involved in controlling autoimmune arthritis
por: Bardos, Tamas, et al.
Publicado: (2003)

Immunoregulatory functions of mature CD10(+) and immature CD10(–) neutrophils in sepsis patients
por: Liu, Ming, et al.
Publicado: (2023)

Multifaceted effects of soluble human CD6 in experimental cancer models
por: Simões, Inês T, et al.
Publicado: (2020)

CD4(+)CD25(+) Immunoregulatory T Cells: New Therapeutics for Graft-Versus-Host Disease
por: Cohen, José L., et al.
Publicado: (2002)

Significance of propolis administration for homeostasis of CD4(+)CD25(+) immunoregulatory T cells controlling hyperglycemia
por: Rifa’i, Muhaimin, et al.
Publicado: (2014)

Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses
por: Carrasco, Esther, et al.
Publicado: (2017)

On the Oral Microbiome of Oral Potentially Malignant and Malignant Disorders: Dysbiosis, Loss of Diversity, and Pathogens Enrichment
por: Herreros-Pomares, Alejandro, et al.
Publicado: (2023)

Immunoregulatory CD4(-)CD8(-) T cells as a potential therapeutic tool for transplantation, autoimmunity, and cancer
por: Hillhouse, Erin E., et al.
Publicado: (2013)

Diminution of Phagocytosed Micro/Nanoparticles by Tethering with Immunoregulatory CD200 Protein
por: Zhang, Jun, et al.
Publicado: (2020)

Myeloid CD169/Siglec1: An immunoregulatory biomarker in viral disease
por: Herzog, Silva, et al.
Publicado: (2022)

Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer
por: Molina-Pinelo, Sonia, et al.
Publicado: (2016)

Identification of Novel Immunoregulatory Molecules in Human Thymic Regulatory CD4(+)CD25(+) T Cells by Phage Display
por: Porto, Georgia, et al.
Publicado: (2011)

Are polymorphisms of the immunoregulatory factor CD40LG implicated in acute transfusion reactions?
por: Aloui, Chaker, et al.
Publicado: (2014)

Immunological consequences of extramedullary erythropoiesis: immunoregulatory functions of CD71(+) erythroid cells
por: Elahi, Shokrollah, et al.
Publicado: (2020)

Role of CD5/CD5L interactions in the homeostasis of regulatory lymphocyte subpopulations and the control of autoimmune disorders
por: Fenutría, Rafael, et al.
Publicado: (2011)

CD4(+)CD25(+) Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production
por: Thornton, Angela M., et al.
Publicado: (1998)

TMPRSS4: A Novel Tumor Prognostic Indicator for the Stratification of Stage IA Tumors and a Liquid Biopsy Biomarker for NSCLC Patients
por: Villalba, Maria, et al.
Publicado: (2019)

Altered expression of the immunoregulatory ligand-receptor pair CD200-CD200R1 in the brain of Parkinson’s disease patients
por: Rabaneda-Lombarte, Neus, et al.
Publicado: (2022)

Analysis of CD95 and CCR7 expression on circulating CD4(+) lymphocytes revealed disparate immunoregulatory potentials in systemic lupus erythematosus
por: Aldahlawi, Alia M., et al.
Publicado: (2016)

The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy
por: Shao, Anqi, et al.
Publicado: (2023)

Identification of a novel synthetic lethal vulnerability in non-small cell lung cancer by co-targeting TMPRSS4 and DDR1
por: Villalba, Maria, et al.
Publicado: (2019)

Expansion in CD39(+) CD4(+) Immunoregulatory T Cells and Rarity of Th17 Cells in HTLV-1 Infected Patients Is Associated with Neurological Complications
por: Leal, Fabio E., et al.
Publicado: (2013)

Soluble CD5 and CD6: Lymphocytic Class I Scavenger Receptors as Immunotherapeutic Agents
por: Velasco-de Andrés, María, et al.
Publicado: (2020)

The death domain kinase RIP1 links the immunoregulatory CD40 receptor to apoptotic signaling in carcinomas
por: Knox, Pauline G., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_pckpfbdrljsai6i695atu1k5s4